医学
射血分数
达帕格列嗪
心力衰竭
心脏病学
内科学
糖尿病
2型糖尿病
内分泌学
作者
Scott D. Solomon,John J.V. McMurray,Brian Claggett,Rudolf A. de Boer,David L. DeMets,Adrian F. Hernandez,Silvio E. Inzucchi,Mikhail Kosiborod,Carolyn S.P. Lam,Felipe A. Martínez,Sanjiv J. Shah,Akshay S. Desai,Pardeep S. Jhund,Jan Bělohlávek,Chern‐En Chiang,C. Jan Willem Borleffs,Josep Comín‐Colet,Dan Dobreanu,Jarosław Dróżdż,James C. Fang
标识
DOI：10.1056/nejmoa2206286
摘要
Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction. (Funded by AstraZeneca; DELIVER ClinicalTrials.gov number, NCT03619213.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
smile
cwn
爱斯维尔无
嘉心糖
无极微光
GingerF
SuiWu
学术文献互助
怕黑水蓝
Alexa
Mowgliw
LiuZfosu
加菲丰丰
一念之间
YifanWang
浮游
乐求知
fukka
大力的灵雁
皖公网安备34019202002308
